Incidentally simultaneous occurrence of RET/PTC, H4–PTEN and BRAF mutation in papillary thyroid carcinoma-Reference-Cited by-同舟云学术

Incidentally simultaneous occurrence of RET/PTC, H4–PTEN and BRAF mutation in papillary thyroid carcinoma

Published:2008-05 Issue:1 Volume:263 Page:44-52
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wang Yu-Long,Wang Jiu-Cun,Wu Yi,Zhang Ling,Huang Cai-Ping,Shen Qiang,Zhu Yong-Xue,Li Duan-Shu,Ji Qing-Hai

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference46 articles.

1. Increasing incidence of thyroid cancer in the United States, 1973–2002;Davies;JAMA,2006

2. Cancer statistics, 2007;Jemal;CA Cancer J. Clin.,2007

3. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma;Kimura;Cancer Res.,2003

4. The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells;Melillo;J. Clin. Invest.,2005

5. BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis;Mitsutake;Endocrinology,2006

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and validation of a nomogram for predicting lateral lymph node metastasis in pediatric and adolescent with differentiated thyroid carcinoma;Endocrine;2024-02-17

2. Combined Mutational and Clonality Analyses Support the Existence of Intra-Tumor Heterogeneity in Papillary Thyroid Cancer;Journal of Clinical Medicine;2021-06-16

3. Association Between Age and Nodal Metastasis in Papillary Thyroid Carcinoma;Otolaryngology–Head and Neck Surgery;2020-10-20

4. Intratumoral Genetic Heterogeneity in Papillary Thyroid Cancer: Occurrence and Clinical Significance;Cancers;2020-02-07

5. Clinical significance of BRAFV600E and TERT promoter mutation in papillary thyroid microcarcinoma*;Oncology and Translational Medicine;2019-04